Plasma DNA tissue mapping by genome-wide methylation sequencing for noninvasive prenatal, cancer, and transplantation assessments

Proceedings of the National Academy of Sciences of the United States of America

Volumn 112, Issue 40, 2015, Pages E5503-E5512

  Sun, Kun ^a,b   Jiang, Peiyong ^a,b   Chan, K C Allen ^a,b   Wong, John ^b   Cheng, Yvonne K Y ^b   Liang, Raymond H S ^c   Chan, Wai Kong ^c   Ma, Edmond S K ^c   Chan, Stephen L ^b   Cheng, Suk Hang ^a,b   Chan, Rebecca W Y ^a,b   Tong, Yu K ^a,b   Ng, Simon S M ^b   Wong, Raymond S M ^b   Hui, David S C ^b   Leung, Tse Ngong ^c   Leung, Tak Y ^b   Lai, Paul B S ^b   Chiu, Rossa W K ^a,b   Lo, Yuk Ming Dennis ^a,b  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c HONG KONG SANATORIUM AND HOSPITAL   (Hong Kong)

Author keywords

Circulating tumor DNA; Epigenetics; Liquid biopsy; Noninvasive prenatal testing; Transplantation monitoring

Indexed keywords

ARTICLE; B LYMPHOCYTE; BONE MARROW TRANSPLANTATION; CANCER GENETICS; CANCER PATIENT; CONTROLLED STUDY; COPY NUMBER VARIATION; DNA METHYLATION; DNA SEQUENCE; FEMALE; FOLLICULAR LYMPHOMA; GENE MAPPING; GENETIC MARKER; GRAFT RECIPIENT; HUMAN; HUMAN TISSUE; LEUKOCYTE; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; NON INVASIVE PROCEDURE; PLACENTA; PLASMA; PREGNANT WOMAN; PRIORITY JOURNAL; ADULT; ALGORITHM; BLOOD; CHEMISTRY; FETUS; GENETICS; LIVER; LIVER TUMOR; METABOLISM; MIDDLE AGED; NEUTROPHIL; PATHOLOGY; PREGNANCY; PROCEDURES; T LYMPHOCYTE; TISSUE TRANSPLANTATION;

DNA;

ADULT; ALGORITHMS; B-LYMPHOCYTES; BONE MARROW TRANSPLANTATION; CARCINOMA, HEPATOCELLULAR; DNA; DNA COPY NUMBER VARIATIONS; DNA METHYLATION; FEMALE; FETUS; HUMANS; LIVER; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MIDDLE AGED; NEUTROPHILS; PLACENTA; PREGNANCY; SEQUENCE ANALYSIS, DNA; T-LYMPHOCYTES; TISSUE TRANSPLANTATION;

EID: 84943375035     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1508736112     Document Type: Article

References (48)

1. Lo YMD, et al (1997) Presence of fetal DNA in maternal plasma and serum. Lancet 350 (9076):485-487.
2. Chiu RWK, et al (2008) Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma. Proc Natl Acad Sci USA 105(51):20458-20463.
3. New MI, et al (2014) Noninvasive prenatal diagnosis of congenital adrenal hyperplasia using cell-free fetal DNA in maternal plasma. J Clin Endocrinol Metab 99(6):E1022-E1030.
4. Bianchi DW, et al; CARE Study Group (2014) DNA sequencing versus standard prenatal aneuploidy screening. N Engl J Med 370(9):799-808.
5. Chiu RWK, et al (2011) Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: Large scale validity study. BMJ 342:c7401.
6. Clausen FB (2014) Integration of noninvasive prenatal prediction of fetal blood group into clinical prenatal care. Prenat Diagn 34(5):409-415.
7. Bayindir B, et al (2015) Noninvasive prenatal testing using a novel analysis pipeline to screen for all autosomal fetal aneuploidies improves pregnancy management. Eur J Hum Genet, 10.1038/ejhg.2014.282.
8. Lo YMD, et al (1999) Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma. Cancer Res 59(6):1188-1191.
9. Yung TKF, et al (2009) Single-molecule detection of epidermal growth factor receptor mutations in plasma by microfluidics digital PCR in non-small cell lung cancer patients. Clin Cancer Res 15(6):2076-2084.
10. Leary RJ, et al (2012) Detection of chromosomal alterations in the circulation of cancer patients with whole-genome sequencing. Sci Transl Med 4(162):162ra154.
11. Chan KCA, et al (2013) Cancer genome scanning in plasma: Detection of tumorassociated copy number aberrations, single-nucleotide variants, and tumoral heterogeneity by massively parallel sequencing. Clin Chem 59(1):211-224.
12. Murtaza M, et al (2013) Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA. Nature 497 (7447):108-112.
13. Lo YMD, et al (1998) Presence of donor-specific DNA in plasma of kidney and livertransplant recipients. Lancet 351 (9112):1329-1330.
14. Snyder TM, Khush KK, Valantine H.A., Quake S.R. (2011) Universal noninvasive detection of solid organ transplant rejection. Proc Natl Acad Sci USA 108(15):6229-6234.
15. Masuzaki H, et al (2004) Detection of cell free placental DNA in maternal plasma: Direct evidence from three cases of confined placental mosaicism. J Med Genet 41(4):289-292.
16. Chen C, et al (2014) A pregnancy with discordant fetal and placental chromosome 18 aneuploidies revealed by invasive and noninvasive prenatal diagnosis. Reprod Biomed Online 29(1):136-139.
17. Bettegowda C, et al (2014) Detection of circulating tumor DNA in early- and latestage human malignancies. Sci Transl Med 6(224):224ra24.
18. Lui YYN, et al (2002) Predominant hematopoietic origin of cell-free DNA in plasma and serum after sex-mismatched bone marrow transplantation. Clin Chem 48(3):421-427.
19. Zheng YW, et al (2012) Nonhematopoietically derived DNA is shorter than hematopoietically derived DNA in plasma: A transplantation model. Clin Chem 58(3):549-558.
20. Fernandez AF, et al (2012) A DNA methylation fingerprint of 1628 human samples. Genome Res 22(2):407-419.
21. Kundaje A, et al; Roadmap Epigenomics Consortium (2015) Integrative analysis of 111 reference human epigenomes. Nature 518 (7539):317-330.
22. Houseman EA, et al (2012) DNA methylation arrays as surrogate measures of cell mixture distribution. BMC Bioinformatics 13:86.
23. Chim SSC, et al (2005) Detection of the placental epigenetic signature of the maspin gene in maternal plasma. Proc Natl Acad Sci USA 102(41):14753-14758.
24. Lun FMF, et al (2013) Noninvasive prenatal methylomic analysis by genomewide bisulfite sequencing of maternal plasma DNA. Clin Chem 59(11):1583-1594.
25. Ou X, et al (2014) Epigenome-wide DNA methylation assay reveals placental epigenetic markers for noninvasive fetal single-nucleotide polymorphism genotyping in maternal plasma. Transfusion 54(10):2523-2533.
26. Jensen TJ, et al (2015) Whole genome bisulfite sequencing of cell-free DNA and its cellular contributors uncovers placenta hypomethylated domains. Genome Biol 16(1):78.
27. Wong IH, et al (1999) Detection of aberrant p16 methylation in the plasma and serum of liver cancer patients. Cancer Res 59(1):71-73.
28. Chan KCA, et al (2013) Noninvasive detection of cancer-associated genome-wide hypomethylation and copy number aberrations by plasma DNA bisulfite sequencing. Proc Natl Acad Sci USA 110(47):18761-18768.
29. Hodges E, et al (2011) Directional DNA methylation changes and complex intermediate states accompany lineage specificity in the adult hematopoietic compartment. Mol Cell 44(1):17-28.
30. Lo YMD, et al (2010) Maternal plasma DNA sequencing reveals the genome-wide genetic and mutational profile of the fetus. Sci Transl Med 2(61):61ra91.
31. Norton ME, et al (2015) Cell-free DNA analysis for noninvasive examination of trisomy. N Engl J Med 372(17):1589-1597.
32. Heitzer E, et al (2013) Establishment of tumor-specific copy number alterations from plasma DNA of patients with cancer. Int J Cancer 133(2):346-356.
33. Yu SCY, et al (2013) Noninvasive prenatal molecular karyotyping from maternal plasma. PLoS One 8(4):e60968.
34. De Vlaminck I., et al (2014) Circulating cell-free DNA enables noninvasive diagnosis of heart transplant rejection. Sci Transl Med 6(241):241ra77.
35. Bianchi DW, et al (2015) Noninvasive prenatal testing and incidental detection of occult maternal malignancies. JAMA 314(2):162-169.
36. Amant F, et al (2015) Presymptomatic identification of cancers in pregnant women during noninvasive prenatal testing. JAMA Oncol, 10.1001/jamaoncol.2015.1883.
37. Laszlo AH, et al (2013) Detection and mapping of 5-methylcytosine and 5-hydroxymethylcytosine with nanopore MspA. Proc Natl Acad Sci USA 110(47):18904-18909.
38. Cheng SH, et al (2015) Noninvasive prenatal testing by nanopore sequencing of maternal plasma DNA: Feasibility assessment. Clin Chem 61(1):172-181.
39. Ng EKO, et al (2003) mRNA of placental origin is readily detectable in maternal plasma. Proc Natl Acad Sci USA 100(8):4748-4753.
40. Tsui NBY, et al (2014) Maternal plasma RNA sequencing for genome-wide transcriptomic profiling and identification of pregnancy-associated transcripts. Clin Chem 60(7):954-962.
41. Koh W, et al (2014) Noninvasive in vivo monitoring of tissue-specific global gene expression in humans. Proc Natl Acad Sci USA 111(20):7361-7366.
42. Chim SSC, et al (2008) Detection and characterization of placental microRNAs in maternal plasma. Clin Chem 54(3):482-490.
43. Wang K, et al (2009) Circulating microRNAs, potential biomarkers for drug-induced liver injury. Proc Natl Acad Sci USA 106(11):4402-4407.
44. Jiang P, et al (2014) Methy-Pipe: An integrated bioinformatics pipeline for whole genome bisulfite sequencing data analysis. PLoS One 9(6):e100360.
45. Kent WJ, et al (2002) The human genome browser at UCSC. Genome Res 12(6):996-1006.
46. Irizarry RA, et al (2009) The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores. Nat Genet 41(2):178-186.
47. van den Meersche K, Soetaert K, van Oevelen D (2009) An R function for sampling linear inverse problems. J Stat Softw 30:1-15.
48. Chen EZ, et al (2011) Noninvasive prenatal diagnosis of fetal trisomy 18 and trisomy 13 by maternal plasma DNA sequencing. PLoS One 6(7):e21791.